Triamcinolone acetonide 0.001 MG/MG Oral Paste [Oralone] — RxCUI 1085767
RxNorm drug concept · Semantic branded drug
RxCUI 1085767
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1085767
Official nameTriamcinolone acetonide 0.001 MG/MG Oral Paste [Oralone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOralone 0.1 % Oral Paste; Oralone 0.001 MG/MG Oral Paste
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
- I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
- That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
- I have diabetes. Should I be worried about using triamcinolone?
🕸️ Concept Web — How Triamcinolone acetonide 0.001 MG/MG Oral Paste [... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Triamcinolone acetonide 0.001 MG/MG Oral Paste [Oralone]
RxCUI 1085767 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Triamcinolone
10759IN -
Triamcinolone acetonide
10761PIN
-
Triamcinolone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Oralone
544401BN
-
Oralone
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Triamcinolone Oral Paste
10760SCDF -
Triamcinolone acetonide Oral Paste
2648295SCDFP -
Triamcinolone Oral Paste Product
1295518SCDG -
Triamcinolone Oral Product
1158228SCDG -
Triamcinolone Paste Product
1158229SCDG -
Triamcinolone acetonide Oral Paste Product
2659485SCDGP -
Triamcinolone acetonide Oral Product
2660917SCDGP -
Triamcinolone acetonide Paste Product
2663005SCDGP - +9 more in this family
-
Triamcinolone Oral Paste
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Triamcinolone acetonide 0.001 MG/MG Oral Paste
1085728SCD -
Triamcinolone acetonide 0.001 MG/MG
857692SCDC -
Triamcinolone acetonide 0.001 MG/MG [Oralone]
1085766SBDC
-
Triamcinolone acetonide 0.001 MG/MG Oral Paste
Showing up to 8 concepts per family — 14 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Triamcinolone acetonide 0.001 MG/MG Oral Paste
SCD · 1085728 -
Triamcinolone acetonide 0.001 MG/MG
SCDC · 857692 -
Triamcinolone Oral Paste
SCDF · 10760 -
Triamcinolone acetonide Oral Paste
SCDFP · 2648295 -
Triamcinolone Oral Paste Product
SCDG · 1295518 -
Triamcinolone Oral Product
SCDG · 1158228 -
Triamcinolone Paste Product
SCDG · 1158229 -
Triamcinolone acetonide Oral Paste Product
SCDGP · 2659485 -
Triamcinolone acetonide Oral Product
SCDGP · 2660917 -
Triamcinolone acetonide Paste Product
SCDGP · 2663005
Brand-Name Concepts
-
Triamcinolone acetonide 0.001 MG/MG [Oralone]
SBDC · 1085766 -
Triamcinolone Oral Paste [Oralone]
SBDF · 707357 -
Triamcinolone acetonide Oral Paste [Oralone]
SBDFP · 2656474 -
Oralone Oral Paste Product
SBDG · 1295793 -
Oralone Oral Product
SBDG · 1183428 -
Oralone Paste Product
SBDG · 1183429 -
Oralone
BN · 544401
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1085767 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51672-1335-05 | 1 TUBE in 1 CARTON (51672-1335-5) / 5 g in 1 TUBE | Oralone | Sun Pharmaceutical Industries, Inc. | 1986-10-01 |
| 51672-1335-08 | 1 TUBE in 1 CARTON (51672-1335-8) / 7.5 g in 1 TUBE | Oralone | Sun Pharmaceutical Industries, Inc. | 1986-10-01 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$2.7895
Range $2.7895–$2.7895
· middle 50% $2.7895–$2.7895
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.